The contractor shall provide niaid with preclinical product development services for candidate products.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N93022D00001
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $680,219 obligated
Award facts
- Opportunity
-
- NIHAI2015029 Solicitation number
- Combined order value
- $680,219 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling <1% used
- $150,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The Lovelace Biomedical Research Institute has been awarded an indefinite delivery contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. With a potential value of $150 million, this single award IDV enables NIAID to procure preclinical product development services for candidate products from Lovelace through July 2023.
Under the IDV, Lovelace has received a $486,301 cost-plus-fixed-fee delivery order to transfer, validate and qualify bioanalytical methods for detecting cabotegravir and levonorgestrel in rat and nonhuman primate plasma. This work will be conducted in Albuquerque, New Mexico over three years through November 2024. The delivery order aims to support NIAID's research on prevention, diagnosis and treatment of HIV/AIDS and other infectious diseases by developing analytical methods for monitoring candidate products in preclinical trials.
Both the IDV and initial task order were awarded without a set-aside designation, reflecting NIAID's goal of procuring specialized preclinical research and development services to advance its infectious disease portfolio.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| The contractor shall perform the transfer, validation and qualification of bioanalytical methods for detection of… | National Institute of Allergy and Infectious Diseases (NIH) | $680,219 |
Quick answers
Who was awarded contract 75N93022D00001?
75N93022D00001 was awarded to Lovelace Biomedical Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on November 1, 2021.
How much is contract 75N93022D00001 worth?
Orders under 75N93022D00001 have obligated $680,219. 75N93022D00001's own ceiling is $150,000,000.
How many orders have been placed under contract 75N93022D00001?
1 order has been placed under 75N93022D00001, the latest on November 15, 2021.
Who can order from contract 75N93022D00001?
75N93022D00001 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N93022D00001 competed?
The extent of competition for 75N93022D00001 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV